Demographic and clinical features of 159 non-morbidly obese patients with histological NAFLD subdivided according to the presence of NASH.

Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis

Wang, Qianyi
You, Hong
Ou, Xiaojuan
Zhao, Xinyan
Sun, Yameng
Wang, Min
Wang, Ping
Wang, Yu
Duan, Weijia
Wang, Xiaoming
Wu, Shanshan
Kong, Yuanyuan
Saxena, Romil
Gouw, Annette S. H.
Jia, Jidong

November 2019

Background and aims Non-alcoholic fatty liver disease (NAFLD) commonly affects subjects with obesity...

Non-Alcoholic Fatty Liver Disease

Hui-Hui Tan MRCP(UK), FAMS
Jason Pik-Eu Chang MMed (Int Med), MRCP(UK)

March 2010

Non-alcoholic fatty liver disease (NAFLD) comprises a disease spectrum ranging from benign hepatic s...

Adults with Nonalcoholic Fatty Liver Disease

Brent A Neuschwander-tetri
Aynur Unalp
Elizabeth M Brunt
Arthur J Mccullough

January 2010

conduct multicenter studies on the etiology, contributing factors, natural history, and treatment of...

Characteristics of the NASH patients according to the presence of obesity.

Jee-Fu Huang (292609)
Ming-Lun Yeh (349881)
Ming-Lung Yu (292600)
Chung-Feng Huang (292606)
Chia-Yen Dai (292610)
Ming-Yen Hsieh (391260)
Meng-Hsuan Hsieh (550259)
Ching-I Huang (391259)
Zu-Yau Lin (292611)
Shinn-Chern Chen (803977)
Pi-Jung Hsiao (508356)
Shyi-Jang Shin (508358)
Wan-Long Chuang (292615)

October 2015

Values expressed as mean ± standard deviation. Parenthesis indicates percentage. NASH, non-alcoho...

Clinical and laboratory data in patients with NAFLD, and the presence or absence of histological signs of NASH.

Karel Dvorak (650760)
Jan Stritesky (650761)
Jaromir Petrtyl (650762)
Libor Vitek (355729)
Renata Sroubkova (650763)
Martin Lenicek (355728)
Vaclav Smid (650764)
Martin Haluzik (650765)
Radan Bruha (650766)

October 2014

BMI: body mass index, GGT: γ-Glutamyltransferase, PIIINP: aminoterminal peptide of pro-collagen I...

Demographic, clinical and histological characteristics of 148 patients with NASH at baseline and comparison of those with and without clinical outcomes.

Giada Sebastiani (204344)
Rasha Alshaalan (756320)
Philip Wong (73144)
Maria Rubino (756321)
Ayat Salman (661317)
Peter Metrakos (71919)
Marc Deschenes (756322)
Peter Ghali (756323)

June 2015

Legend: Results given as mean ± SD or n (%). BMI, body mass index. IU, international units; ALT, ...

Clinical and serological characteristics of the biopsy-proven NAFLD patients.

Yoshihiro Kamada (425228)
Maaya Akita (425229)
Yuri Takeda (425230)
Shin Yamada (425231)
Hideki Fujii (425232)
Yoshiyuki Sawai (425233)
Yoshinori Doi (425234)
Hitomi Asazawa (425235)
Kotarosumitomo Nakayama (425236)
Kayo Mizutani (425237)
Hironobu Fujii (425238)
Takayuki Yakushijin (425239)
Masanori Miyazaki (425240)
Hisao Ezaki (425241)
Naoki Hiramatsu (425242)
Yuichi Yoshida (425243)
Shinichi Kiso (425244)
Yasuharu Imai (158670)
Norifumi Kawada (425245)
Tetsuo Takehara (425246)
Eiji Miyoshi (343973)

June 2013

Data are presented as the mean ± SD.Abbreviations: BMI, body mass index; AST, aspartate am...

Clinical characteristics of subjects with and without NASH.

Vincent Wai-Sun Wong (210913)
Chi-Hang Tse (407333)
Tommy Tsan-Yuk Lam (218347)
Grace Lai-Hung Wong (256904)
Angel Mei-Ling Chim (407334)
Winnie Chiu-Wing Chu (407335)
David Ka-Wai Yeung (407336)
Patrick Tik-Wan Law (407337)
Hoi-Shan Kwan (407338)
Jun Yu (5904)
Joseph Jao-Yiu Sung (210918)
Henry Lik-Yuen Chan (210922)

April 2013

Continuous variables were expressed as mean ± standard deviation or median (interquartile range)....

Demographic and clinical data of the NAFLD patients.

Shamsul Mohd Zain (386147)
Zahurin Mohamed (386148)
Sanjiv Mahadeva (132198)
Sanjay Rampal (132194)
Roma Choudhury Basu (386149)
Phaik-Leng Cheah (386150)
Agus Salim (167207)
Rosmawati Mohamed (132206)

March 2013

ALT alanine transferase, AST aspartate aminotransferase, BMI body mass index...

Clinical data of patients with NAFLD/NASH and chronic viral hepatitis.

Michiko Itoh (496082)
Hideaki Kato (496083)
Takayoshi Suganami (219173)
Kuniha Konuma (496084)
Yoshio Marumoto (496085)
Shuji Terai (496086)
Hiroshi Sakugawa (496087)
Sayaka Kanai (219176)
Miho Hamaguchi (496088)
Takahiro Fukaishi (496089)
Seiichiro Aoe (496090)
Kazunari Akiyoshi (496091)
Yoshihiro Komohara (414247)
Motohiro Takeya (414255)
Isao Sakaida (156599)
Yoshihiro Ogawa (15560)

December 2013

± SE. **P<0.01. NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic s...

for the NASH

September 2016

conduct multicenter studies on the etiology, contributing factors, natural history, and treatment of...

[Non-alcoholic steatohepatitis - from NAFLD to MAFLD]

Balmer, Maria Luisa
Dufour, Jean-François

January 2011

Non-alcoholic steatohepatitis (NASH) as one entity of non-alcoholic fatty liver disease (NAFLD) is t...

CUHK electronic theses & dissertations collection

January 2009

Among NAFLD patients without known diabetes or high fasting plasma glucose at or above 7.0 mmol/I, 2...

Demographic and clinical features of 159 NAFLD patients according to the risk of OSAS with or without daytime sleepiness.

Edoardo Alessandro Pulixi (555451)
Eleonora Tobaldini (223646)
Pier Maria Battezzati (555452)
Paola D'Ingianna (555453)
Vittorio Borroni (555454)
Anna Ludovica Fracanzani (314259)
Marco Maggioni (216401)
Serena Pelusi (300537)
Mara Bulgheroni (555455)
Massimo Zuin (555456)
Silvia Fargion (300540)
Nicola Montano (136455)
Luca Valenti (300533)

April 2014

Data are shown as Mean ± SD (% values) according to data distribution; P value: at ANOVA; *P<0.05...

Grading of NASH according to histopathological findings.

Maricruz Sepulveda-Villegas (6175610)
Sonia Roman (844085)
Ingrid Rivera-Iñiguez (6175613)
Claudia Ojeda-Granados (6175616)
Karina Gonzalez-Aldaco (844083)
Luis Alberto Torres-Reyes (6175619)
Alexis Jose-Abrego (6175622)
Arturo Panduro (844092)

January 2019

NAFLD, nonalcoholic fatty liver disease; NAFL: nonalcoholic fatty liver; NASH, nonalcoholic steatohe...

Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis

Wang, Qianyi
You, Hong
Ou, Xiaojuan
Zhao, Xinyan
Sun, Yameng
Wang, Min
Wang, Ping
Wang, Yu
Duan, Weijia
Wang, Xiaoming
Wu, Shanshan
Kong, Yuanyuan
Saxena, Romil
Gouw, Annette S. H.
Jia, Jidong

November 2019

Background and aims Non-alcoholic fatty liver disease (NAFLD) commonly affects subjects with obesity...

Non-Alcoholic Fatty Liver Disease

Hui-Hui Tan MRCP(UK), FAMS
Jason Pik-Eu Chang MMed (Int Med), MRCP(UK)

March 2010

Non-alcoholic fatty liver disease (NAFLD) comprises a disease spectrum ranging from benign hepatic s...

Adults with Nonalcoholic Fatty Liver Disease

Brent A Neuschwander-tetri
Aynur Unalp
Elizabeth M Brunt
Arthur J Mccullough

January 2010

conduct multicenter studies on the etiology, contributing factors, natural history, and treatment of...

Characteristics of the NASH patients according to the presence of obesity.

Jee-Fu Huang (292609)
Ming-Lun Yeh (349881)
Ming-Lung Yu (292600)
Chung-Feng Huang (292606)
Chia-Yen Dai (292610)
Ming-Yen Hsieh (391260)
Meng-Hsuan Hsieh (550259)
Ching-I Huang (391259)
Zu-Yau Lin (292611)
Shinn-Chern Chen (803977)
Pi-Jung Hsiao (508356)
Shyi-Jang Shin (508358)
Wan-Long Chuang (292615)

October 2015

Values expressed as mean ± standard deviation. Parenthesis indicates percentage. NASH, non-alcoho...

Clinical and laboratory data in patients with NAFLD, and the presence or absence of histological signs of NASH.

Karel Dvorak (650760)
Jan Stritesky (650761)
Jaromir Petrtyl (650762)
Libor Vitek (355729)
Renata Sroubkova (650763)
Martin Lenicek (355728)
Vaclav Smid (650764)
Martin Haluzik (650765)
Radan Bruha (650766)

October 2014

BMI: body mass index, GGT: γ-Glutamyltransferase, PIIINP: aminoterminal peptide of pro-collagen I...

Demographic, clinical and histological characteristics of 148 patients with NASH at baseline and comparison of those with and without clinical outcomes.

Giada Sebastiani (204344)
Rasha Alshaalan (756320)
Philip Wong (73144)
Maria Rubino (756321)
Ayat Salman (661317)
Peter Metrakos (71919)
Marc Deschenes (756322)
Peter Ghali (756323)

June 2015

Legend: Results given as mean ± SD or n (%). BMI, body mass index. IU, international units; ALT, ...

Clinical and serological characteristics of the biopsy-proven NAFLD patients.

Yoshihiro Kamada (425228)
Maaya Akita (425229)
Yuri Takeda (425230)
Shin Yamada (425231)
Hideki Fujii (425232)
Yoshiyuki Sawai (425233)
Yoshinori Doi (425234)
Hitomi Asazawa (425235)
Kotarosumitomo Nakayama (425236)
Kayo Mizutani (425237)
Hironobu Fujii (425238)
Takayuki Yakushijin (425239)
Masanori Miyazaki (425240)
Hisao Ezaki (425241)
Naoki Hiramatsu (425242)
Yuichi Yoshida (425243)
Shinichi Kiso (425244)
Yasuharu Imai (158670)
Norifumi Kawada (425245)
Tetsuo Takehara (425246)
Eiji Miyoshi (343973)

June 2013

Data are presented as the mean ± SD.Abbreviations: BMI, body mass index; AST, aspartate am...

Clinical characteristics of subjects with and without NASH.

Vincent Wai-Sun Wong (210913)
Chi-Hang Tse (407333)
Tommy Tsan-Yuk Lam (218347)
Grace Lai-Hung Wong (256904)
Angel Mei-Ling Chim (407334)
Winnie Chiu-Wing Chu (407335)
David Ka-Wai Yeung (407336)
Patrick Tik-Wan Law (407337)
Hoi-Shan Kwan (407338)
Jun Yu (5904)
Joseph Jao-Yiu Sung (210918)
Henry Lik-Yuen Chan (210922)

April 2013

Continuous variables were expressed as mean ± standard deviation or median (interquartile range)....

Demographic and clinical data of the NAFLD patients.

Shamsul Mohd Zain (386147)
Zahurin Mohamed (386148)
Sanjiv Mahadeva (132198)
Sanjay Rampal (132194)
Roma Choudhury Basu (386149)
Phaik-Leng Cheah (386150)
Agus Salim (167207)
Rosmawati Mohamed (132206)

March 2013

ALT alanine transferase, AST aspartate aminotransferase, BMI body mass index...

Clinical data of patients with NAFLD/NASH and chronic viral hepatitis.

Michiko Itoh (496082)
Hideaki Kato (496083)
Takayoshi Suganami (219173)
Kuniha Konuma (496084)
Yoshio Marumoto (496085)
Shuji Terai (496086)
Hiroshi Sakugawa (496087)
Sayaka Kanai (219176)
Miho Hamaguchi (496088)
Takahiro Fukaishi (496089)
Seiichiro Aoe (496090)
Kazunari Akiyoshi (496091)
Yoshihiro Komohara (414247)
Motohiro Takeya (414255)
Isao Sakaida (156599)
Yoshihiro Ogawa (15560)

December 2013

± SE. **P<0.01. NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic s...

for the NASH

September 2016

conduct multicenter studies on the etiology, contributing factors, natural history, and treatment of...

[Non-alcoholic steatohepatitis - from NAFLD to MAFLD]

Balmer, Maria Luisa
Dufour, Jean-François

January 2011

Non-alcoholic steatohepatitis (NASH) as one entity of non-alcoholic fatty liver disease (NAFLD) is t...

CUHK electronic theses & dissertations collection

January 2009

Among NAFLD patients without known diabetes or high fasting plasma glucose at or above 7.0 mmol/I, 2...

Demographic and clinical features of 159 NAFLD patients according to the risk of OSAS with or without daytime sleepiness.

Edoardo Alessandro Pulixi (555451)
Eleonora Tobaldini (223646)
Pier Maria Battezzati (555452)
Paola D'Ingianna (555453)
Vittorio Borroni (555454)
Anna Ludovica Fracanzani (314259)
Marco Maggioni (216401)
Serena Pelusi (300537)
Mara Bulgheroni (555455)
Massimo Zuin (555456)
Silvia Fargion (300540)
Nicola Montano (136455)
Luca Valenti (300533)

April 2014

Data are shown as Mean ± SD (% values) according to data distribution; P value: at ANOVA; *P<0.05...

Grading of NASH according to histopathological findings.

Maricruz Sepulveda-Villegas (6175610)
Sonia Roman (844085)
Ingrid Rivera-Iñiguez (6175613)
Claudia Ojeda-Granados (6175616)
Karina Gonzalez-Aldaco (844083)
Luis Alberto Torres-Reyes (6175619)
Alexis Jose-Abrego (6175622)
Arturo Panduro (844092)

January 2019

NAFLD, nonalcoholic fatty liver disease; NAFL: nonalcoholic fatty liver; NASH, nonalcoholic steatohe...

Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis

Wang, Qianyi
You, Hong
Ou, Xiaojuan
Zhao, Xinyan
Sun, Yameng
Wang, Min
Wang, Ping
Wang, Yu
Duan, Weijia
Wang, Xiaoming
Wu, Shanshan
Kong, Yuanyuan
Saxena, Romil
Gouw, Annette S. H.
Jia, Jidong

November 2019

Background and aims Non-alcoholic fatty liver disease (NAFLD) commonly affects subjects with obesity...

Non-Alcoholic Fatty Liver Disease

Hui-Hui Tan MRCP(UK), FAMS
Jason Pik-Eu Chang MMed (Int Med), MRCP(UK)

March 2010

Non-alcoholic fatty liver disease (NAFLD) comprises a disease spectrum ranging from benign hepatic s...

Adults with Nonalcoholic Fatty Liver Disease

Brent A Neuschwander-tetri
Aynur Unalp
Elizabeth M Brunt
Arthur J Mccullough

January 2010

conduct multicenter studies on the etiology, contributing factors, natural history, and treatment of...

Demographic and clinical features of 159 non-morbidly obese patients with histological NAFLD subdivided according to the presence of NASH.

Abstract

Extracted data

Demographic and clinical features of 159 non-morbidly obese patients with histological NAFLD subdivided according to the presence of NASH.

Abstract

Extracted data

Related items

Related items